Jiali Wang

833 total citations
34 papers, 620 citations indexed

About

Jiali Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiali Wang has authored 34 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jiali Wang's work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (10 papers) and Circular RNAs in diseases (8 papers). Jiali Wang is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (10 papers) and Circular RNAs in diseases (8 papers). Jiali Wang collaborates with scholars based in China, United States and Luxembourg. Jiali Wang's co-authors include Tianxu Liu, Yuqing Duan, Wei Lv, Lihua Liu, Yunlong Jia, Lihua Liu, Mengjie Wang, Hongyan Wang, Xing Liang and Yu Wang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hazardous Materials and Oncogene.

In The Last Decade

Jiali Wang

34 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiali Wang China 16 475 337 61 50 46 34 620
Zhijun Huang China 17 608 1.3× 326 1.0× 55 0.9× 75 1.5× 65 1.4× 55 766
Tongbao Feng China 13 402 0.8× 353 1.0× 31 0.5× 107 2.1× 90 2.0× 25 672
Aijun Yang China 13 290 0.6× 186 0.6× 36 0.6× 48 1.0× 54 1.2× 34 493
Xiaoyi Li China 15 532 1.1× 348 1.0× 26 0.4× 100 2.0× 36 0.8× 40 739
Li R China 13 365 0.8× 264 0.8× 66 1.1× 45 0.9× 49 1.1× 49 579
Zhenyu Xu China 11 833 1.8× 769 2.3× 47 0.8× 51 1.0× 56 1.2× 25 1.0k

Countries citing papers authored by Jiali Wang

Since Specialization
Citations

This map shows the geographic impact of Jiali Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiali Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiali Wang more than expected).

Fields of papers citing papers by Jiali Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiali Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiali Wang. The network helps show where Jiali Wang may publish in the future.

Co-authorship network of co-authors of Jiali Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiali Wang. A scholar is included among the top collaborators of Jiali Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiali Wang. Jiali Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yan, Jiali Wang, Boyang Zheng, et al.. (2024). NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. Cell Death Discovery. 10(1). 131–131. 21 indexed citations
2.
Cao, Fangfang, Yuanyuan Li, Ting Peng, et al.. (2024). PTEN in kidney diseases: a potential therapeutic target in preventing AKI-to-CKD transition. Frontiers in Medicine. 11. 1428995–1428995. 3 indexed citations
3.
Liu, Jiaxin, Yi Wan, Fei Chen, et al.. (2023). Hybridization chain reaction cascaded amplification platform for sensitive detection of pathogen. Talanta. 265. 124829–124829. 4 indexed citations
4.
Qin, Jing, Jiali Wang, Wei Lv, et al.. (2023). Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665–HMGB1 axis. Journal of Gastrointestinal Oncology. 14(3). 1259–1278. 5 indexed citations
5.
Wang, Jiali, Wensi Zhang, Yuhang Xu, et al.. (2023). RNA extraction-free workflow integrated with a single-tube CRISPR-Cas-based colorimetric assay for rapid SARS-CoV-2 detection in different environmental matrices. Journal of Hazardous Materials. 454. 131487–131487. 29 indexed citations
6.
Wang, Jiali, Chengqiang Mo, Xiaopeng Mao, et al.. (2022). CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1. Oncogene. 41(33). 3979–3990. 32 indexed citations
8.
Wang, Jiali, et al.. (2022). [Curcumin targeting miR-155-5p/TP53INP1 axis induced oxidative stress to regulate salivary gland tumor cell proliferation and apoptosis].. PubMed. 31(5). 483–490. 1 indexed citations
9.
Wang, Dan, et al.. (2021). Knockdown of sorcin increases HEI-OC1 cell damage induced by cisplatin in vitro. Archives of Biochemistry and Biophysics. 701. 108752–108752. 3 indexed citations
10.
Wang, Jiali, et al.. (2021). Hsa_circ_0043278 Inhibits Tumorigenesis and is Downregulated in Colorectal Cancer. Cancer Management and Research. Volume 13. 965–975. 7 indexed citations
11.
Duan, Yuqing, Jiali Wang, Tianxu Liu, et al.. (2021). Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1. Cell Death and Disease. 12(6). 587–587. 34 indexed citations
13.
Wang, Jiali, Tianxu Liu, Mengjie Wang, et al.. (2019). SRSF1‐dependent alternative splicing attenuates BIN1 expression in non–small cell lung cancer. Journal of Cellular Biochemistry. 121(2). 946–953. 26 indexed citations
15.
Huang, Xufei, Jian Sun, Junliang Lu, et al.. (2019). Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival. Amyloid. 27(1). 36–44. 11 indexed citations
16.
Li, Li, Haifeng Zhang, Xiaolong Wang, Jiali Wang, & Haitao Wei. (2018). Long non-coding RNA CASC2 enhanced cisplatin-induced viability inhibition of non-small cell lung cancer cells by regulating the PTEN/PI3K/Akt pathway through down-regulation of miR-18a and miR-21. RSC Advances. 8(29). 15923–15932. 11 indexed citations
17.
Xia, Quan, Jiali Wang, Dongling Zhang, et al.. (2017). Proteomic analysis of cell cycle arrest and differentiation induction caused by ATPR, a derivative of all‐trans retinoic acid, in human gastric cancer SGC‐7901 cells. PROTEOMICS - CLINICAL APPLICATIONS. 11(7-8). 21 indexed citations
18.
Wang, Chunyan, et al.. (2016). Effect of miRNA-27a and Leptin Polymorphisms on Risk of Recurrent Spontaneous Abortion. Medical Science Monitor. 22. 3514–3522. 16 indexed citations
19.
Chen, Jinghong, et al.. (2010). Effects of T-2 toxin and selenium on chondrocyte expression of matrix metalloproteinases (MMP-1, MMP-13), α2-macroglobulin (α2M) and TIMPs. Toxicology in Vitro. 25(2). 492–499. 30 indexed citations
20.
Wang, Jiali, Jeannette C. Miller, & Arnold J. Friedhoff. (1997). Differential regulation of D2 receptor gene expression by transcription factor AP-1 in cultured cells. Journal of Neuroscience Research. 50(1). 23–31. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026